Guanhao Biotech Co.,Ltd. (SHE:300238)
China flag China · Delayed Price · Currency is CNY
14.76
-0.23 (-1.53%)
Mar 30, 2026, 3:04 PM CST

Guanhao Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
14.7927.4231.01-307.8273.69
Depreciation & Amortization
25.6526.6129.0133.0438.8
Other Amortization
0.951.265.968.0911.03
Loss (Gain) From Sale of Assets
0.01-0.03-0.92-0.03-0.33
Asset Writedown & Restructuring Costs
1.984.980.29217.940.19
Loss (Gain) From Sale of Investments
-1.8910.233.6441.364.68
Provision & Write-off of Bad Debts
-8.566.728.912.7
Other Operating Activities
5.32-8.92.9352.99-6.22
Change in Accounts Receivable
17.7619.9611.1240.0514.17
Change in Inventory
-0.63-2.13-5.849.2-14.98
Change in Accounts Payable
8.13-36.83-27.87-54.31-15.12
Operating Cash Flow
71.4749.5554.1570.98122.39
Operating Cash Flow Growth
44.23%-8.49%-23.71%-42.00%17.87%
Capital Expenditures
-38.17-76.2-53.92-41.17-4.71
Sale of Property, Plant & Equipment
0.030.10.010.035.03
Cash Acquisitions
-0.9-3.56---0.15
Divestitures
--2.8-0.77-0.13
Investment in Securities
2.84-5.28-1.892.66
Investing Cash Flow
-36.19-84.95-51.11-40.022.7
Short-Term Debt Issued
----52
Long-Term Debt Issued
45.018537.550-
Total Debt Issued
45.018537.55052
Short-Term Debt Repaid
-----153.25
Long-Term Debt Repaid
-20.01-38.94-63.62-116.97-13.05
Total Debt Repaid
-20.01-38.94-63.62-116.97-166.3
Net Debt Issued (Repaid)
2546.06-26.12-66.97-114.3
Issuance of Common Stock
6.1----
Common Dividends Paid
-3.67-2.46-1.21-3.68-6.97
Other Financing Activities
-6.42----0.5
Financing Cash Flow
21.0243.59-27.32-70.65-121.78
Foreign Exchange Rate Adjustments
-0.180.180.080.69-0.21
Net Cash Flow
56.128.38-24.21-38.993.11
Free Cash Flow
33.3-26.650.2329.81117.68
Free Cash Flow Growth
---99.22%-74.67%16.59%
Free Cash Flow Margin
8.59%-7.06%0.06%7.90%24.07%
Free Cash Flow Per Share
0.12-0.100.000.110.45
Cash Income Tax Paid
44.7338.7746.5639.9330.81
Levered Free Cash Flow
19.5-13.6824.8652.485.69
Unlevered Free Cash Flow
19.5-13.0325.9754.9790.3
Change in Working Capital
24.67-20.57-24.4716.49-2.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.